Advanced Search
Contact | Corporate | Help

Rituximab in the Treatment of Idiopathic Membranous Nephropathy

Sponsors:
  • Mayo Clinic
  • Genentech
Phases:
  • Phase II
  • Phase III
IndicationsAcronym:
  • Membranous Nephropathy
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Rituximab
Enrollment:
20

Additional information about NCT00405340.


SourceSolution © 2008-2012